Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

A Study of LY3435151 in Participants With Solid Tumors

A Study of LY3435151 in Participants With Solid Tumors
Conditions:   Solid Tumor;   Triple-negative Breast Cancer;   Gastric Adenocarcinoma;   Head and Neck Squamous Cell Carcinoma;   Cervical Carcinoma;   High Grade Serous Ovarian Carcinoma;   Hepatocellular Carcinoma;   Undifferentiated Pleomorphic Sarcoma;   Leiomyosarcoma
Interventions:   Drug: LY3435151;   Drug: Pembrolizumab
Sponsor:   Eli Lilly and Company

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 6, 2019 / by / in